708 Proanthocyanidin treatment significantly decreases the levels of iron, ACSL4, and ALOX15 in spinal cord tissue of SCI mice, while increasing GSH, GPX4, Nrf2, and HO-1, improving motor function of SCI mice
Market Dynamics and Growth Prospects The dramatic weight loss results achieved with GLP-1 agonistsoften between 15-25%have spurred market growth, far surpassing the performance of earlier medications
Lyophilised (freeze-dried) peptide
The GLP-1 receptor activation produces the most familiar effects
Human evidence: Yes, observational studies exist, though they are older and lack modern control standards
Three modifications, one engineering goal: stop the molecule being cleaved, slow the molecule being cleared